Jones Eleanor L, Wee Janet L, Demaria Maria C, Blakeley Jessica, Ho Po Ki, Vega-Ramos Javier, Villadangos Jose A, van Spriel Annemiek B, Hickey Michael J, Hämmerling Günther J, Wright Mark D
Department of Immunology and Pathology, Monash University, Melbourne, Victoria 3004, Australia;
Department of Immunology and Pathology, Monash University, Melbourne, Victoria 3004, Australia; Department of Medicine, Centre for Inflammatory Diseases, Monash University, Clayton, Victoria 3168, Australia;
J Immunol. 2016 Feb 1;196(3):978-87. doi: 10.4049/jimmunol.1500357. Epub 2016 Jan 4.
This study supports a new concept where the opposing functions of the tetraspanins CD37 and CD82 may coordinate changes in migration and Ag presentation during dendritic cell (DC) activation. We have previously published that CD37 is downregulated upon monocyte-derived DC activation, promotes migration of both skin and bone marrow-derived dendritic cells (BMDCs), and restrains Ag presentation in splenic and BMDCs. In this article, we show that CD82, the closest phylogenetic relative to CD37, appears to have opposing functions. CD82 is upregulated upon activation of BMDCs and monocyte-derived DCs, restrains migration of skin and BMDCs, supports MHC class II maturation, and promotes stable interactions between T cells and splenic DCs or BMDCs. The underlying mechanism involves the rearrangement of the cytoskeleton via a differential activation of small GTPases. Both CD37(-/-) and CD82(-/-) BMDCs lack cellular projections, but where CD37(-/-) BMDCs spread poorly on fibronectin, CD82(-/-) BMDCs are large and spread to a greater extent than wild-type BMDCs. At the molecular level, CD82 is a negative regulator of RhoA, whereas CD37 promotes activation of Rac-1; both tetraspanins negatively regulate Cdc42. Thus, this study identifies a key aspect of DC biology: an unactivated BMDC is CD37(hi)CD82(lo), resulting in a highly motile cell with a limited ability to activate naive T cells. By contrast, a late activated BMDC is CD37(lo)CD82(hi), and thus has modified its migratory, cytoskeletal, and Ag presentation machinery to become a cell superbly adapted to activating naive T cells.
本研究支持一个新的概念,即四跨膜蛋白CD37和CD82的相反功能可能在树突状细胞(DC)激活过程中协调迁移和抗原呈递的变化。我们之前发表过,单核细胞来源的DC激活后CD37表达下调,促进皮肤和骨髓来源的树突状细胞(BMDC)迁移,并抑制脾细胞和BMDC中的抗原呈递。在本文中,我们表明,与CD37亲缘关系最近的CD82似乎具有相反的功能。BMDC和单核细胞来源的DC激活后CD82表达上调,抑制皮肤和BMDC迁移,支持MHC II类分子成熟,并促进T细胞与脾DC或BMDC之间的稳定相互作用。潜在机制涉及通过小GTP酶的差异激活来重排细胞骨架。CD37(-/-)和CD82(-/-) BMDC均缺乏细胞突起,但CD37(-/-) BMDC在纤连蛋白上铺展不佳,而CD82(-/-) BMDC体积大且比野生型BMDC铺展程度更大。在分子水平上,CD82是RhoA的负调节因子,而CD37促进Rac-1的激活;这两种四跨膜蛋白均负调节Cdc42。因此,本研究确定了DC生物学的一个关键方面:未激活的BMDC是CD37(高)CD82(低),导致细胞高度迁移但激活初始T细胞的能力有限。相比之下,晚期激活的BMDC是CD37(低)CD82(高),因此其迁移、细胞骨架和抗原呈递机制已发生改变,成为一个非常适合激活初始T细胞的细胞。